XOMA Co. (NASDAQ:XOMAO – Get Free Report) saw a large decline in short interest in January. As of January 15th, there was short interest totaling 5,711 shares, a decline of 37.6% from the December 31st total of 9,148 shares. Based on an average daily trading volume, of 4,276 shares, the days-to-cover ratio is currently 1.3 days. Based on an average daily trading volume, of 4,276 shares, the days-to-cover ratio is currently 1.3 days.
XOMA Trading Down 0.0%
Shares of XOMAO stock opened at $25.39 on Friday. XOMA has a 1 year low of $23.32 and a 1 year high of $25.76. The business’s fifty day moving average is $25.41 and its 200-day moving average is $25.43.
About XOMA
XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.
In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.
Further Reading
- Five stocks we like better than XOMA
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
